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Lung cancer carries the highest cancer-related mortality throughout
the world and has an incidence of about 60 new cases per year in
100 000 people (Pisani et al, 1993). The major distinction of clin-
ical importance is made between small-cell lung cancer (SCLC)
(~20%) and non-small-cell lung cancer (NSCLC) (~80%). The
histopathological diagnosis of SCLC is highly predictable for the
clinical course since almost every tumour has metastasized at the
time of diagnosis, or will do so within the near future. In contrast, it
is far more difficult to predict the outcome of NSCLC based on
morphological grounds. Some tumours are similar to SCLC with a
highly aggressive behaviour and early metastasis formation,
whereas others may be cured after surgery or remain stable for a
considerable period of time even in the case of residual disease.
Squamous cell carcinomas (SCCs) together with adeno-
carcinomas constitute the two major subtypes of NSCLC.
Adenocarcinomas are typically located in the lung periphery and
often cause first symptoms by a distant metastasis. In contrast,
SCCs develop preferentially from the bronchial epithelium of the
central lung and may present regional lymph node metastases prior
to haematogeneous spread. However, the distribution of blood-
borne metastases is similar in both entities affecting almost any
organ, but with preference to the liver, bone, adrenal gland and the
nervous system.
The genetic mechanisms underlying lung cancer development
and progression are only beginning to emerge. Many defects have
only been described on the chromosomal level and, although
several genetic lesions have been identified, many still remain
unknown. The chromosome regions identified by allelotyping
suggesting the involvement of tumour suppressor genes include
1p, 2q, 3p, 4p, 4q, 5q, 6p, 6q, 8p, 9p, 10q, 11p, 11q, 14q, 17q, 18q
and 22q (Sekido et al, 1998). Comparative genomic hybridization
(CGH) also detected deletions at 1p, 2q, 3p, 4p, 4q, 5q, 6q, 8p, 9p,
10q, 11p, 11q, 13q, 17p, 18p, 18q and 21q, as well as over-
representations on 1q, 3q, 5p, 8q, 11q13, 12p, 17q, 19q, 20q and
22q (Ried et al, 1994; Levin et al, 1994, 1995; Petersen et al,
1997a, 1997b; Schwendel et al, 1997).
We recently took advantage of the fact that the primary data in
CGH are derived from digital analysis of fluorescence images and
are already computerized to calculate histograms and difference
histograms for statistical analysis of tumour groups (Petersen et al,
1997b). In the present study we applied this approach to evaluate
the incidence of chromosomal alterations in SCC and to highlight
chromosomal subregions being associated with the metastatic
phenotype. The statistical analysis of the tumour subgroups was
supplemented by the direct comparison of primary and metastatic
tumours in ten cases.
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SummaryComparative genomic hybridization (CGH) was applied to squamous cell carcinomas (SCC) of the lung to define chromosomal
imbalances that are associated with the metastatic phenotype. In total, 64 lung SCC from 50 patients were investigated, 25 each with or
without evidence of metastasis formation. The chromosomal imbalances summarized by a CGH histogram of the 50 cases revealed deletions
most frequently on chromosomes 1p21–p31, 2q34–q36, 3p, 4p, 4q, 5q, 6q14–q24, 8p, 9p, 10q, 11p12–p14, 13q13–qter, 18q12–qter and
21q21. DNA over-representations were most pronounced for chromosomes 1q11–q25, 1q32–q41, 3q, 5p, 8q22–qter, 11q13, 12p,
17q21–q22, 17q24–q25, 19, 20q and 22q. In ten cases, paired samples of primaries and at least one metastasis were analysed. The
comparison revealed a considerable chromosomal instability and genetic heterogeneity; however, the CGH pattern indicated a clonal
relationship in each case. The difference in histograms from the metastatic and non-metastatic tumour groups was most useful in pinpointing
chromosomal imbalances associated with the metastatic phenotype, indicating that the deletions at 3p12–p14, 3p21, 4p15–p16, 6q24–qter,
8p22–p23, 10q21–qter and 21q22, as well as the over-representations at 1q21–q25, 8q, 9q34, 14q12 and 15q12–q15, occurred significantly
more often in the metastatic tumour group. The comparison of the paired samples confirmed these findings in individual cases and suggested
distinct genetic changes, in particular the extension of small interstitial deletions, during tumour progression. Importantly, metastasis-
associated lesions were frequently detectable in the primary tumour providing a method of identifying patients at risk for tumour
dissemination. Individual profiles and histograms are accessible at our web site http://amba.charite.de/cgh. © 2000 Cancer Research
Campaign
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Tumour samples
Tumour specimens were mainly obtained from surgical resections
at the Department of Surgery of the Charité Hospital at the
Humboldt University Berlin. Operation specimens were trans-
ferred to the Institute of Pathology within 1 h after surgical
removal. Generally, no adjuvant radiotherapy or chemotherapy
was applied before surgery. Additionally, tumour specimens of
primary and metastatic lesions were collected at post-mortem
examinations at the Pathology Institutes of the Charité, the
University Hospital of Kiel and the University Hospital of Zurich.
These specimens were frozen 3–48 h after the patients died. One
aliquot was frozen in liquid nitrogen and kept at –80°C until DNA
extraction. DNA was extracted from several 30 mm cryostat tissue
sections by proteinase K and phenol–chloroform extraction which
was verified to consist of a minimum of 70% tumour cells in each
case. A second aliquot was submitted to formalin fixation and
paraffin embedding. The histopathological diagnosis was estab-
lished in every case according to the WHO guidelines on haema-
toxylin and eosin (H&E)-stained tissue sections (WHO, 1981).
Samples from 50 patients with SCC were investigated. One
group consisted of 25 non-metastatic (pN0/pM0) tumours that
were derived from surgical resections, except one autopsy case
(L101, no information on treatment). In the second group, 19
primary and 20 metastatic lesions (18 haematogeneous and two
lymph node metastases) from another 25 patients, seven with stage
pN2 and 18 with stage pM1 disease, were investigated. Of these,
15 cases were autopsy cases (radiotherapy in six cases: L24, L26,
L29, L30, L34, L36; no treatment in seven cases: L23, L27, L33,
L35, L37, L39, L40; no information on treatment in two cases:
L28, L31) and ten resections. Paired samples of primary tumour
and corresponding metastases were analysed in ten cases (seven
autopsy cases: L23, L27, L31, L34, L37, L39, L40; three resec-
tions: L171, L219, L220).
Comparative genomic hybridization
Chromosome metaphase spreads, DNA labelling, hybridization
and detection were performed as described previously (Petersen et
al, 1997a, 1997b). Briefly, tumour and normal DNA were differ-
entially labelled with biotin-16–dUTP and digoxigenin-11–dUTP
(both Boehringer Mannheim, Germany) respectively. One micro-
gram of each tumour and normal DNA, together with 30 mg
human Cot1 DNA and 10 mg salmon sperm DNA were ethanol
precipitated and applied to denatured and dried normal metaphase
spreads. After 3 days of hybridization at 37°C, the tumour and
normal genomes were specifically detected by avidin–FITC
(fluorescein isothiocyanate; Vector Laboratories) and anti-
digoxigenin–rhodamin–TRITC (Boehringer Mannheim,
Germany) respectively. The chromosomes were counterstained
with 4,6-diamino-2-phenolindol dihydrochloride (DAPI) and
embedded in 90% glycerol containing 2.3% 4,6-diazabi-
cyclo[2.2.2]octane (Sigma Aldrichs).
Digital image analysis
Fluorescence images were obtained with a Zeiss Axiophot epiflu-
orescence microscope in conjunction with a 12-bit cooled charge-
coupled device camera (Photometrics, Tucson, AZ, USA). Three
images per metaphase spread were acquired, quantitated as 8-bit
grey level images and stored in a TIFF-format. The DAPI image
was used for chromosome identification. FITC and TRITC,
specific for the tumour and reference genome, respectively, were
used to compute fluorescence ratio images and ratio profiles.
Generally, 15 metaphases per karyogram were analysed for each
case. CGH sum-karyograms as well as mean ratio profiles with
confidence intervals (CI) were calculated (Petersen et al, 1997a;
Roth et al, 1997).
Statistical determination of chromosomal imbalances
Alterations were determined by calculating the mean
FITC–TRITC profile with its 95% and 99% CIs. The profile was
tested for significant deviations from the normal ratio of 1.0 by a
Student’s t-test (Bockmühl et al, 1997; Petersen et al, 1997b). This
type of evaluation constitutes a quite sensitive measure for evalua-
tion of DNA imbalances which is best explained by the example of
Figure 2B. In case L37, the ratio profile of the primary tumour on
the left showed only minute deviations from the normal ratio value
of 1.0 represented by the middle line. The left and right lines repre-
sent the 0.75 and 1.25 ratio respectively. If these fixed thresholds,
or even the less restrictive 0.8 or 1.2 thresholds were applied for
the determination, no DNA imbalance would be scored. The statis-
tical method, however, already counts those deviations in which
the profile together with its CI is on one side of the 1.0 ratio line,
e.g. the deletion at 10q23–q25.
We used the fixed ratio values 1.5 and 0.5 as thresholds to
define pronounced DNA gains and losses respectively. The 1.5
ratio threshold has been already used by us to define high copy
amplifications in SCLC (Petersen et al, 1997a). Similarly,
pronounced DNA losses probably correspond to multicopy dele-
tions within the tumour genome.
After the statistical determination of the chromosomal imbal-
ances of each tumour, a histogram of all cases was calculated
(Figure 1A). It includes one tumour sample per case and represents
the incidence of DNA gains and losses of the tumour group along
each chromosome, e.g. the maximum value of 100% is reached if
all tumours of the same tumour group carry a change at a specific
chromosomal region. The two significance levels are indicated by
distinct colours: blue areas indicate those alterations with 99%
significance, whereas the green areas include those with 95%
significance. In addition, pronounced DNA copy number changes
are depicted in red.
Statistical comparison of tumour subgroups
The alterations with 99% significance were included into the
difference histogram of Figure 1B. It represents the genetic imbal-
ances of non-metastatic and metastatic SCC providing a statistical
comparison of the two subgroups. Again, one tumour per case was
included into the histogram, with preference for metastatic lesions
in the pM1/pN2 subgroup. The primary tumour was used in ten
cases (L24, L36, L33, L41, L42, L44, L143, L157, L172, L245),
in which no metastasis was available. The percentage of changes
occurring only in the pN0/M0 tumours is represented by the green
colour, whereas the excess of changes in the metastatic tumour
group is shown in red. The white areas beneath the coloured part
of the histogram represent the percentage of changes that are
present in both subgroups. A large coloured area thus indicates a
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Figure 1 (A) Summary of the chromosomal alterations in 50 SCCs of the lung in a histogram representation. The chromosomal imbalances are shown as
incidence curves along each chromosome. Areas on the left side of the chromosome ideogram correspond to loss of genetic material; those on the right side
correspond to DNA gains. The frequency of the alterations can be determined from the 0.5 (50%) and 1.0 (100%) incidence lines depicted parallel to the
chromosome ideograms. DNA changes with 99% significance are coloured in blue, additional changes with 95% significance are depicted in green. The
proportion of pronounced DNA gains and losses being defined as imbalances for which the ratio profiles exceeded the thresholds of 1.5 and 0.5, respectively,
are visualized in red. They are most likely to represent high copy amplifications or multicopy deletions. The centromeric regions especially of chromosomes 1, 9,
13, 14, 15, 16, 19, 21 and 22, and the sex chromosomes must be excluded from the evaluation. (B) Difference histogram between non-metastatic and
metastatic SCC of the lung. Green, percentage of changes that are exclusively present in non-metastatic SCC. Red, excess of changes in metastatic tumours.
White areas beneath the coloured parts of each histogram, percentage of changes that are present in both tumour subgroups. Grey horizontal lines, statistically
significant differences between non-metastatic and metastatic lung SCC. Light grey lines, regions with 95% significance; dark grey lines, 99% significance
according to the c2 test. Again, the centromeric regions must be excluded due to variability of fluorescence signals in these regions.CGH in primary and metastatic lung SCCs 69
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Figure 2 (A) The CGH results of a primary tumour (case L39) and two of its liver metastases are shown by a line representation. Lines on the left side of the
ideograms represent deletions, lines on the right side indicate DNA gains. The alterations of the primary tumour are depicted in the indexed position proximal to
the chromosome ideogram, the lines in the middle position and the third position from the ideogram correspond to a large and small liver metastases
respectively. The aberration pattern of chromosomes 4, 5, 6p, 8p, 9, 10q, 11p, 18 and 20 clearly indicates the clonal relationship between the three tumours. In
addition, the comparison of the alterations of chromosomes 2q, 6q and 8 revealed that these deletions had expanded during tumour progression. (B) Examples
of specific chromosome ratio profiles of three primary tumours (left) and their corresponding metastases (right). The profiles are shown along with the 99%
confidence interval. The number of chromosomes included into the statistical analysis are indicated at each chromosome ideogram. The example of
chromosome 1 suggested that the overrepresentation of the entire long arm was reduced to a DNA gain of the region 1q21–q25 most probably carrying the
metastasis-associated gene. The example of chromosome 8 indicates the intensification of chromosomal change with the transition from low copy to high copy
imbalances. The example of chromosome 10 suggests a triggering effect of small interstitial deletions.pronounced difference between the tumour groups. The differ-
ences were tested for significance by a c2 test. Areas with 95%
significance (0.01 < P < 0.05) are depicted in bright grey, and
areas with 99% significance (P < 0.01) are depicted in dark grey.
Detailed protocols of the preparation and digital image
analysis have been published previously (Petersen et al, 1997a ,
1997b; Roth et al, 1997) and are available on our website
http://amba.charite.de/cgh.
RESULTS
The chromosomal imbalances of 50 lung SCCs are summarized in
Figure 1A by a histogram representation. One tumour per patient
was included in the histogram. The most prevalent deletions with
an incidence of more than 50% were observed for chromosomes
1p21–p31, 2q34–q36, 3p, 4p, 4q, 5q, 6q14–q24, 8p, 9p, 10q,
11p12–p14, 13q13–qter, 18q12–qter and 21q21. In addition, the
following regions were slightly less frequently affected by dele-
tions (30% < incidence ≤ 50%): 1p34–p36, 2q22–q33, 2q37,
9q13–q31, 10p, 11q14–qter, 12q21, 14q21, 15q21 and 17p.
Most prevalent DNA over-representations (> 50%) were seen
on chromosomes 1q11–q25, 1q32–q41, 3q, 5p, 8q22–qter, 11q13,
12p, 17q21–q22, 17q24–q25, 19, 20q and 22q and less frequently
(30% < incidence ≤ 50%) on 1p32–pter, 2pter–2q21, 2q24–q32,
6p11–p21, 7, 8q11–q21, 9q22–q34, 12q23–q24.3, 14, 15q11–q14,
15q23–q25, 16p and 18p11.2–q11.2.
Pronounced DNA copy number changes generally co-localized
with peaks of the incidence curve, i.e. deletions at 1p22–p31,
3p12–p14, 4p14–p15.1, 8p12–p22, 9p21, 10q21, 10q23,
11p13–p14, 11q14–q22, 11q24–q25, 13q21–q31, 14q21, 15q21,
18q12–q21, 18q22 and 21q21, and over-representations at
1q21–q25, 1q32–q41, 2q31, 3q27–q28, 5p15.3, 6p12, 7p21–p22,
7p12–p13, 7q21–q22, 8q13–q21.1, 8q22, 8q24.1, 9q34, 11q13,
12p, 12q13, 13q33–q34, 14q23–q24, 17q21–q22, 17q24–q25,
18q11, 19p13.3, 19q13–1. q13.2, 20p12, 20q and 22q.
In general, lung SCC showed a very complex pattern of DNA
imbalances in which almost any chromosome region was affected
by DNA gains and losses. The only exception was the over-repre-
sentation of chromosome 3p that was never observed even by our
quite sensitive statistical method for the determination of copy
number changes.
The direct comparison of ten primary tumours and their corre-
sponding metastases is summarized in Table 1. It revealed a large
number of common changes between the tumours of the same
patient, indicating a clonal relationship as well as a considerable
number of aberrant alterations. Thus, the interpretation of this data
is complicated by the considerable genetic instability and hetero-
geneity of lung carcinomas. Therefore we decided to focus on the
comparison of tumour groups, i.e. metastatic and non-metastatic
lung SCC, since it facilitates the identification of those imbalances
relevant for the metastatic phenotype by reducing the influence of
tumour heterogeneity.
The statistical analysis of the metastatic and non-metastatic
SCC by a difference histogram is represented in Figure 1B. It is
based on the comparison of 25 primary tumours without evidence
of metastases formation at the time of diagnosis, i.e. of stage
pN0/M0, and 25 metastasizing carcinomas. Only few chromo-
somal regions carry an excess of changes in the non-metastatic
subgroup represented by the green colour when compared to
the metastatic carcinomas. One such region was observed on
chromosome 5p which, however, failed to achieve statistical
significance. The overall excess of changes in the metastatic
tumour group is visible by the prevailing red colour in the differ-
ence histogram.
For the most prevalent imbalance region (incidence > 50%), the
statistical comparison using the c2 test indicated that DNA losses
of the chromosome regions 3p12–p14, 3p21, 4p15–p16, 8p22–p23
and 10q21–qter, as well as the over-representations of the chromo-
somal bands 1q21–q25 and several regions on 8q, were associated
with a statistical significance for the metastatic phenotype. For the
less frequent changes (30% < incidence ≤ 50%), the statistical
analysis indicated in addition deletions on 6q24–qter and 21q22,
and the DNA gains at 9q34, 14q12 and 15q12–q15. These
chromosomal regions were consistently found when different
evaluation schemes, i.e. using fixed ratio thresholds and statistical
methods, were applied for the determination of the imbalances
of individual cases. These different evaluation schemes are
accessible at our web site http://amba.charite.de/cgh. For single
chromosome regions, there was, however, a certain variability for
locus assignment.
The direct comparison of ten primary tumours and their corre-
sponding metastases confirmed the results of the statistical
comparison of the tumour subgroups since single cases showed the
statistically significant changes additionally in the metastatic
lesions. In the majority of cases, however, these changes were
already detectable in the primary tumour. In addition, the compar-
ison suggested distinct genetic changes in the evolution of
chromosomal imbalances during tumour progression. Typical
examples of the comparison are shown in Figure 2. The CGH
analysis of a primary tumour and two liver metastases is shown in
Figure 2A. One metastasis measured 2.5 cm and the other 1 cm in
diameter. The profiles for chromosomes 2q, 6q and 8 indicated
that size of deletions increased during tumour progression. The
deletion on chromosome 3p including the band 3p12 was not
detectable in the primary tumour.
In Figure 2B, examples of specific chromosome ratio profiles of
three primary tumours and one of their corresponding metastases
is shown. The example of chromosome 1 indicated that the over-
representation of the entire long arm was reduced to a DNA gain
of the region 1q21–q25, which is the region that was also indicated
by the statistical comparison of the tumour subgroups thus most
probably carrying the metastasis-associated gene. We observed an
identical transition twice exclusively for chromosome 1q. The
example of chromosome 8 indicates the intensification of chromo-
somal change with the transition from low copy to high copy
imbalances. The example of chromosome 10 suggests a triggering
effect of small imbalances. Again it illustrates the extension of
deletions during tumour progression, which was a general finding
and does not seem to be restricted to specific chromosomes. 
The detailed comparison of the primary tumours and their metas-
tases is listed in Table 1. The profiles and line representations 
of all ten cases can also be accessed at our web page
http://amba.charite.de/cgh.
DISCUSSION
In the present study we used CGH to define the frequency of
chromosomal imbalances in a collective of lung SCC and to search
for genetic alterations that are associated with the metastatic
phenotype.
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The histogram of 50 lung SCCs indicates the incidence of DNA
gains and losses at specific chromosome sites providing an
overview of those regions that are characteristically affected in this
tumour entity. We applied a quite sensitive method for the determi-
nation of chromosomal imbalances. It is based on the statistical
evaluation whether the deviation of the ratio profile from the
normal ratio value 1.0 is significant or not. In contrast to the
evaluation by fixed thresholds, no specific ratio values were
defined to score a DNA gain or loss. The comparison in sensitivity
can be seen by the profile of tumour L37 in Figure 2B. Since the
profile with its confidence interval of the primary tumour shows a
deviation from the normal ratio value 1.0, DNA imbalances are
scored by the statistical method, whereas no change would be
detected by using the ratio thresholds 0.75 and 1.25 (e.g. Joos et al,
1995), or even the more sensitive values of 0.85 and 1.15 (e.g.
Tarkkanen et al, 1995). The threshold-based methods used in the
initial period of CGH, which are still very popular, are probably
partially responsible for the higher frequency of DNA gains
compared to DNA losses that have been detected in many studies.
Although statistical evaluation is evolving as the method of choice
(Moore et al, 1997; Kirchhoff et al, 1998), there is not yet a
consensus about the best way to determine DNA changes by CGH.
The higher sensitivity of the statistical method does correlate to
the relatively high incidence of imbalances observed in this study.
Although the exact frequency still needs to be determined, the
histogram does visualize the most frequently affected sites and
their relative importance. Another advantage of the histogram
representation is the fact that it enables the statistical comparison
of tumour subgroups. To our knowledge it provides the first
method to search genome wide for phenotype–genotype correla-
tions (Petersen et al, 1997b). Again, for this comparison it is
important that DNA gains and losses are detected with equal sensi-
tivity. The good correlation of the result of the difference
histogram with our allelotyping analysis, which was performed on
the similar tumour collective, supports the validity of our CGH
findings (Petersen et al, 1998a, 1998b). We identified several
candidate regions associated with metastasis formation and
tumour progression. Although the exact localization of corre-
sponding genetic defects needs to be confirmed by future studies
we think that the overall complexity of the CGH pattern corre-
sponds well with the intricacy of systemic tumour dissemination.
Chromosomal alterations associated with the
metastatic phenotype
The difference histogram suggested that the deletions of several
chromosomal regions were statistically significant for the
metastatic phenotype, e.g. deletions at 3p12–p14, 3p21, 4p15–p16,
6q24–qter, 8p22–p23, 10q21–qter and 21q22. Some of these
regions have already been implicated in tumour progression and
metastases formation in other neoplasms, supporting the hypoth-
esis that many features of tumour cell dissemination are not
specific for one entity but are shared between multiple tumour
types.
Deletions of the chromosome band 4p16 have recently been
observed more frequently in metastases of colorectal carcinomas
than in primary tumours (Paredes-Zaglul et al, 1998). In SCLC,
Levin et al observed a metastatic lesion with a deletion of chromo-
some 4p that was not detectable in the primary tumour (Levin et al,
1995). For chromosomes 6q, 8p and 10q there is functional as well
as genetic evidence suggesting that they harbour genes that are
important in metastases formation. Chromosome transfer experi-
ments revealed that they were able to suppress the metastatic
potential of either rodent or human cell lines (Welch et al, 1994;
Ichikawa et al, 1996). Three regions of allelic loss on chromosome
8p have been defined, particularly in high grade head and neck
SCC (Wu et al, 1997). Deletions of chromosome 10q have been
described in multiple advanced solid tumours. We previously
showed that loss of heterozygosity (LOH) was significantly more
frequent in metastatic tumours and defined three distinct regions of
allelic imbalance. Meanwhile, several candidate genes have been
identified most of which, however, seem to be of minor impor-
tance in lung cancer (Petersen et al, 1998a, 1998b).
Regarding chromosome 21q there have been only limited data
that it is involved in tumour progression. Deletions on 21q were
recently found to be statistically more significant in brain metas-
tases of NSCLC than in early stage primary tumours (Kohno et al,
1998).
Chromosome 3p has been implicated particularly in tumour
initiation (Hung et al, 1995). Interestingly, our data suggested that
deletions of 3p12–p14 are important for cancer progression.
Whereas non-metastatic tumours more frequently carry interstitial
deletions, the aggressive carcinomas showed the loss of the entire
chromosome arm including the band 3p12–p14. This is a typical
finding in SCLC (Petersen et al, 1997a).
In general, the analysis by the difference histogram strengthens
the notion that the accumulation of deletions with the putative
inactivation of tumour suppressor genes is particularly important
for haematogeneous tumour spread. However, there were also
some DNA over-representations associated with the metastatic
phenotype, e.g. gains of 1q21–q25, 8q, 9q34, 14q12 and
15q12–q15.
The over-representation on chromosome 1q21–25 being of 95%
significance has been previously reported in metastatic renal cell
carcinomas (Gronwald et al, 1997). DNA gains on 8q, and in
particular amplifications of the c-myc proto-oncogene at 8q24, are
genetic markers for tumour progression (Brison et al, 1993).
Recently the 8q gain along with the 8p loss has been found in bone
metastases of prostate cancer (Alers et al, 1997). To our knowl-
edge the gains at 9q34 and 15q11–q13 have not yet been reported
in advanced tumour stages. The chromosomal band 9q34 as well
as chromosomes 19, 22q and the very telomeric regions, e.g. 8q24,
might give rise to false positive results in CGH analysis (Moore
et al, 1997; Kirchhoff et al, 1998). Nevertheless, we feel that these
over-representations are valuable findings since we also observed
high copy over-representations of these regions which can not be
simply regarded as CGH artefacts. The Abe gene is one candidate
for the 9q34 region. For chromosome 15q, only allelic loss has
been so far observed in association with the metastatic phenotype
of breast carcinomas (Wick et al, 1996).
Chromosomal alterations in the clonal evolution of
metastatic tumour cells
In general, the observation that metastatic lung SCCs carry more
chromosomal alterations than the pM0 tumours supports the
hypothesis that they are derived from non-metastatic precursors by
the acquisition of additional changes, suggesting a clonal evolu-
tion. This clonal relationship was confirmed in each of the ten cases
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study in SCLC (Schwendel et al, 1997). However, it is in contrast to
CGH studies on other tumour entities in which clonality could not
be established in every case (Kuukasjarvi et al, 1997). This seeming
discrepancy can be explained by several factors. First, tumour
heterogeneity might heavily influence the establishment of genetic
correlations especially if there is a long latency period for the occur-
rence of metastases. Second, normal cell contamination and the
quality of tumour DNA may reduce the sensitivity for the detection
of chromosomal imbalances by CGH (Isola et al, 1994). We investi-
gated exclusively synchronous metastases and DNA from frozen
tumour tissue that was controlled for the amount of contaminating
normal tissue in each case.
The comparison of primary tumours and their corresponding
metastases confirmed the findings of the statistical analysis by the
difference histogram in single cases. Additionally it suggested
distinct genetic changes during the process of tumour progression
being exemplified in Figure 2. First, for chromosome 1q we
observed twice over-representations of the entire chromosome arm
in the primary tumours, whereas the metastases showed DNA gain
or even amplification of single bands. This correlates with the
finding that gene amplifications are typically found in advanced
tumour stages (Brison et al, 1993). Second, as a more general
finding we observed that small interstitial deletions were often
extended to large DNA under-representations that affected
chromosome arms or even entire chromosomes. This observation
points to the importance of triggering effects in the evolution of
chromosomal defects. Third, the genetic changes were often more
pronounced in the metastatic lesion. This might be explained by
the fact that out of the genetically heterogeneous primaries those
cells which carry a selection advantage for tumour dissemination
are enriched in the metastatic lesions. In addition, the metastatic
lesions do generally have a less pronounced contamination by
normal tissue.
In summary, we identified several chromosomal imbalances
that were associated with the metastatic phenotype of lung SCC,
offering new candidate regions for the identification of metastasis-
associated genes. Importantly, the specific chromosome defects
were frequently detectable in the primary tumours thus offering a
mean to evaluate the patient risk by the analysis of biopsies or
tumour resections. Although these changes were generally not
simultaneously detectable in a single case it is obviously the accu-
mulation that mediates the potential for tumour dissemination. The
complexity of the genetic changes already detectable by CGH
clearly indicates that it will be necessary to monitor a large number
of genes to evaluate the malignant potential of a tumour. The
identification of these genes and their role in tumour progression
will be a fascinating task in the forthcoming years. Despite the
limitation of CGH being the fact that it does not detect defects of
specific genes its power to provide a comprehensive picture of the
chromosomal alterations has revealed a remarkable pheno-
type–genotype correlation in lung carcinomas. Therefore CGH
does supply valuable information for a refined tumour characteri-
zation and may serve as a paradigm for the feasibility of a genetic
classification of solid tumours.
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